These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32710269)
41. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19. Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417 [TBL] [Abstract][Full Text] [Related]
42. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Lippi G; Salvagno GL; Pegoraro M; Militello V; Caloi C; Peretti A; Gaino S; Bassi A; Bovo C; Lo Cascio G Clin Chem Lab Med; 2020 Jun; 58(7):1156-1159. PubMed ID: 32301750 [No Abstract] [Full Text] [Related]
43. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2. Hu X; An T; Situ B; Hu Y; Ou Z; Li Q; He X; Zhang Y; Tian P; Sun D; Rui Y; Wang Q; Ding D; Zheng L J Clin Lab Anal; 2020 Sep; 34(9):e23411. PubMed ID: 32594577 [TBL] [Abstract][Full Text] [Related]
44. Value and Validity of Coronavirus Antibody Testing. Mahajan A; Manchikanti L Pain Physician; 2020 Aug; 23(4S):S381-S390. PubMed ID: 32942795 [TBL] [Abstract][Full Text] [Related]
45. Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis. Liu W; Kou G; Dong Y; Zheng Y; Ding Y; Ni W; Wu W; Tang S; Xiong Z; Zhang Y; Liu L; Zheng S J Clin Virol; 2020 Sep; 130():104576. PubMed ID: 32763810 [TBL] [Abstract][Full Text] [Related]
47. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests. Traugott M; Aberle SW; Aberle JH; Griebler H; Karolyi M; Pawelka E; Puchhammer-Stöckl E; Zoufaly A; Weseslindtner L J Infect Dis; 2020 Jul; 222(3):362-366. PubMed ID: 32473021 [TBL] [Abstract][Full Text] [Related]
48. Rapid Detection of COVID-19 by Serological Methods and the Evaluation of Diagnostic Efficacy of IgM and IgG. Huang S; Lin C; Yan M; Li H; Liu T; Michael W; Xiang J; Shen C Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180423 [TBL] [Abstract][Full Text] [Related]
49. Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients. Pan Y; Li X; Yang G; Fan J; Tang Y; Zhao J; Long X; Guo S; Zhao Z; Liu Y; Hu H; Xue H; Li Y J Infect; 2020 Jul; 81(1):e28-e32. PubMed ID: 32283141 [TBL] [Abstract][Full Text] [Related]
50. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698 [TBL] [Abstract][Full Text] [Related]
51. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. Demey B; Daher N; François C; Lanoix JP; Duverlie G; Castelain S; Brochot E J Infect; 2020 Aug; 81(2):e6-e10. PubMed ID: 32389784 [TBL] [Abstract][Full Text] [Related]
53. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study. Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C Front Immunol; 2020; 11():581338. PubMed ID: 33123167 [TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. Wei J; Zhao J; Han M; Meng F; Zhou J J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811 [TBL] [Abstract][Full Text] [Related]
55. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test. Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769 [No Abstract] [Full Text] [Related]
56. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019. Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234 [TBL] [Abstract][Full Text] [Related]
57. SARS-CoV-2 IgG antibody responses in New York City. Reifer J; Hayum N; Heszkel B; Klagsbald I; Streva VA Diagn Microbiol Infect Dis; 2020 Nov; 98(3):115128. PubMed ID: 32777699 [TBL] [Abstract][Full Text] [Related]
58. Serum IgA, IgM, and IgG responses in COVID-19. Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617 [No Abstract] [Full Text] [Related]
59. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak. Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214 [TBL] [Abstract][Full Text] [Related]